Suchergebnisse - "Ritonavir"

PubPharm (345)

1

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

2

Brief Report : No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Shaffer, D. | Kumwenda, J. | Chen, H. | +12

3

Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Kendall, M. | Lalloo, U. | Fletcher, C. | +5

4

A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir : a study of HIV-infected Zimbabwean adolescents

enthalten in: BMC pharmacology & toxicology | 2020

von Ngara, B. | Zvada, S. | Chawana, T. | +3

5

Switching protease inhibitors to rilpivirine in HIV-positive individuals with complete viral suppression and without prior HIV drug resistance in a resource-limited setting : a randomized controlled trial

enthalten in: Journal of the International AIDS Society | 2020

von Palanuphap, K. | Sungkanuparph, S.

6

Pharmacokinetic profile and safety of adjusted doses of darunavir/ritonavir with rifampicin in people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Ebrahim, I. | Maartens, G. | Wiesner, L. | +3

7

Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine : a secondary analysis of the ANRS 12174 trial

enthalten in: The lancet. HIV | 2019

von Blanche, S. | Tylleskär, T. | Peries, M. | +9

CommentIn: Lancet HIV. 2019 May;6(5):e272-e273. - PMID 30814029

8

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Bednasz, C. | Venuto, C. | Ma, Q. | +10

9

Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients : ATLAS-M substudy

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Belmonti, S. | Lombardi, F. | Quiros-Roldan, E. | +31

10

Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia

enthalten in: AIDS (London, England) | 2018

von Leyes, P. | Cofan, M. | González-Cordón, A. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]